Food contact notification to FDA

Biotage AB (publ) through its subsidiary MIP Technologies AB submits Food
Contact Notification (FCN) to U.S. Food and Drug Administration (FDA)
Biotage acquired MIP Technologies in 2010 to gain access to world class
development capabilities of custom designed molecular imprinted and other novel
polymers. Following the acquisition Biotage has invested in the
industrialization of MIP Technologies’ business operations. MIP Technologies is
in the process of developing a range of Industrial Resins for use within food
and related industries.

MIP Technologies has now submitted a Food Contact Notification (FCN) to U.S.
Food and Drug Administration (FDA) for the product RENSA™ 101, which may be used
for removal of unwanted impurities in flavoring oils that are used in food. The
approval process with the FDA is expected to be finalized in Q2 2013.

“There is such a great need for products that can enhance food security by
taking out substances that might be harmful to human. I am really pleased to see
that we are part of that movement. It is yet early days for RENSA 101, but we
hope that this product eventually will be commercialized in an industrial scale
setting. We believe in this business and we will continue to invest. “, says
Torben Jörgensen, CEO & President of Biotage.

Contact:
Torben Jörgensen, President and CEO
Tel: +46 707 49 05 84, torben.jorgensen@biotage.com

Tel+46 18 56 59 00
www.biotage.com

Biotage discloses the information provided herein pursuant to the Swedish
Securities Markets Act and/or the Swedish Financial Instruments Trading Act. The
information was submitted for publication at 10.00 on Monday 4 March 2013.

About Biotage
Biotage offers solutions, knowledge and experience in the areas of analytical
chemistry, medicinal chemistry, separation and purification. The customers
include pharmaceutical and biotech companies, companies within the food industry
and leading academic institutes. The company is headquartered in Uppsala and has
offices in the US, UK, China and Japan. Biotage has approx. 290 employees and
had sales of 463 MSEK in 2012. Biotage is listed on the NASDAQ OMX Nordic
Stockholm stock exchange. Website: www.biotage.com